Sanofi is investigated for allegedly bribing doctors in ChinaBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5074 (Published 12 August 2013) Cite this as: BMJ 2013;347:f5074
- Nigel Hawkes
Sanofi, the largest French drug manufacturer, has been drawn into growing anti-bribery investigations in China after a newspaper there published a whistleblower’s claims that it had paid 1.6m yuan (£169 000; €197 000; $261 000) to more than 500 doctors at 79 hospitals in 2007.
Sanofi said in a statement that it took the claims very seriously and was committed to collaborating with the Chinese authorities. “It would be premature to comment on events that may or may not have occurred in 2007,” the statement added.
The reports say the payments were described as research grants and were …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial